1. Home
  2. SYNA vs AMRX Comparison

SYNA vs AMRX Comparison

Compare SYNA & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYNA
  • AMRX
  • Stock Information
  • Founded
  • SYNA 1986
  • AMRX 2002
  • Country
  • SYNA United States
  • AMRX United States
  • Employees
  • SYNA N/A
  • AMRX N/A
  • Industry
  • SYNA Computer peripheral equipment
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SYNA Technology
  • AMRX Health Care
  • Exchange
  • SYNA Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • SYNA 3.2B
  • AMRX 2.7B
  • IPO Year
  • SYNA 2002
  • AMRX N/A
  • Fundamental
  • Price
  • SYNA $74.64
  • AMRX $8.47
  • Analyst Decision
  • SYNA Strong Buy
  • AMRX Strong Buy
  • Analyst Count
  • SYNA 11
  • AMRX 5
  • Target Price
  • SYNA $99.60
  • AMRX $10.00
  • AVG Volume (30 Days)
  • SYNA 495.6K
  • AMRX 1.1M
  • Earning Date
  • SYNA 11-07-2024
  • AMRX 11-08-2024
  • Dividend Yield
  • SYNA N/A
  • AMRX N/A
  • EPS Growth
  • SYNA N/A
  • AMRX N/A
  • EPS
  • SYNA 3.95
  • AMRX N/A
  • Revenue
  • SYNA $979,400,000.00
  • AMRX $2,680,420,000.00
  • Revenue This Year
  • SYNA $13.30
  • AMRX $17.56
  • Revenue Next Year
  • SYNA $15.55
  • AMRX $3.23
  • P/E Ratio
  • SYNA $18.89
  • AMRX N/A
  • Revenue Growth
  • SYNA N/A
  • AMRX 12.32
  • 52 Week Low
  • SYNA $67.83
  • AMRX $4.16
  • 52 Week High
  • SYNA $121.37
  • AMRX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • SYNA 51.19
  • AMRX 45.78
  • Support Level
  • SYNA $71.80
  • AMRX $7.52
  • Resistance Level
  • SYNA $81.49
  • AMRX $9.48
  • Average True Range (ATR)
  • SYNA 3.22
  • AMRX 0.35
  • MACD
  • SYNA 0.42
  • AMRX 0.02
  • Stochastic Oscillator
  • SYNA 49.60
  • AMRX 48.59

About SYNA Synaptics Incorporated $0.001 Par Value

Synaptics Inc is a producer of semiconductor solutions for the mobile, PC, and Internet of Things markets. The company develops human interface solutions that enable touch, display, fingerprint, video, audio, voice, AI, and connectivity functions for smartphones, PCs, Internet of Things products, and other electronic devices. Geographically, it derives a majority of revenue from China. The company operates in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: